Otsuka Counts The Cost Of Alzheimer’s Agitation Fail
The group will take a $770m impairment charge thanks to the Phase III failure of AVP-786 – but further trials continue.
The group will take a $770m impairment charge thanks to the Phase III failure of AVP-786 – but further trials continue.